Marshall Gordon

November 1st, 2020

Marshall is a Senior Research Analyst, covering health care. He joined ClearBridge Investments in 2008 and has 20 years of investment industry experience. Prior to joining ClearBridge, he was a Health Care Analyst on the Large Cap Growth Team at Bear Stearns Asset Management. He was previously a Senior Analyst covering Medical Supplies & Devices and an Associate Analyst covering U.S. Major Pharmaceuticals at Credit Suisse; an Associate Analyst covering Global Biotechnology at Sanford C. Bernstein & Co., LLC; and an Associate in the Life Sciences Group at Lazard Freres & Co. LLC. Marshall received an MBA from the University of Chicago and holds a BS in Finance from the Wharton School of the University of Pennsylvania.

Marshall’s health care research involves the following key ESG considerations: Broad benefit of medicines & cost effectiveness of medicines and devices; Quality of management & validity of strategies for reinvestment.